Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
Top Cited Papers
Open Access
- 1 March 2014
- journal article
- case report
- Published by Elsevier BV in International Journal of Infectious Diseases
- Vol. 20, 42-46
- https://doi.org/10.1016/j.ijid.2013.12.003
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapyInternational Journal of Infectious Diseases, 2013
- Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive studyThe Lancet Infectious Diseases, 2013
- Family Cluster of Middle East Respiratory Syndrome Coronavirus InfectionsThe New England Journal of Medicine, 2013
- Middle East Respiratory Syndrome coronavirus (MERS CoV): Update 2013Current Infectious Disease Reports, 2013
- Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003Tropical Medicine & International Health, 2004
- Severe acute respiratory syndrome: report of treatment and outcome after a major outbreakThorax, 2004
- Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR ChinaJournal of Medical Microbiology, 2003
- A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong KongThe New England Journal of Medicine, 2003
- Identification of Severe Acute Respiratory Syndrome in CanadaThe New England Journal of Medicine, 2003
- Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective studyThe Lancet, 2003